Amy Marie Yule, MD

Assistant Professor, Psychiatry

Amy Yule
617.414.1936
720 Harrison Ave

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • University of California, Los Angeles, MD
  • University of California, San Diego, BS

Publications

  • Published on 5/5/2022

    Wozniak J, DiSalvo M, Farrell A, Yule A, Joshi G, Cook E, Faraone SV, Biederman J. Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole. J Psychopharmacol. 2022 May; 36(5):637-644. PMID: 35510655.

    Read at: PubMed
  • Published on 5/4/2022

    Wilens TE, Woodward DW, Ko JD, Berger AF, Burke C, Yule AM. The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders. J Child Adolesc Psychopharmacol. 2022 May; 32(4):200-214. PMID: 35587209.

    Read at: PubMed
  • Published on 2/23/2022

    Noyes EA, Dunleavy S, Mail V, Plakas I, Keyes S, Gaeta JM, Obando A, Paci E, Lent C, Regis C, Taveras EM, Yule AM, Chatterjee A. Awareness, Utilization, and Preferences of Harm Reduction Interventions among Street-Involved Young Adults in Boston. Subst Use Misuse. 2022; 57(5):827-832. PMID: 35195488.

    Read at: PubMed
  • Published on 1/26/2022

    Yue H, Mail V, DiSalvo M, Borba C, Piechniczek-Buczek J, Yule AM. Patient Preferences for Patient Portal-Based Telepsychiatry in a Safety Net Hospital Setting During COVID-19: Cross-sectional Study. JMIR Form Res. 2022 Jan 26; 6(1):e33697. PMID: 34932497.

    Read at: PubMed
  • Published on 1/19/2022

    Usher C. Family Matters. J Am Acad Child Adolesc Psychiatry. 2022 04; 61(4):575. PMID: 35065188.

    Read at: PubMed
  • Published on 12/26/2021

    McKowen J, Woodward D, Yule AM, DiSalvo M, Rao V, Greenbaum J, Joshi G, Wilens TE. Characterizing autistic traits in treatment-seeking young adults with substance use disorders. Am J Addict. 2022 03; 31(2):108-114. PMID: 34957636.

    Read at: PubMed
  • Published on 8/16/2021

    Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Z Kinder Jugendpsychiatr Psychother. 2021 Jan; 50(1):54-67. PMID: 34397296.

    Read at: PubMed
  • Published on 8/7/2021

    Yule AM, DiSalvo M, Biederman J, Wilens TE, Dallenbach NT, Taubin D, Joshi G. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder. Eur Child Adolesc Psychiatry. 2021 Aug 07. PMID: 34363537.

    Read at: PubMed
  • Published on 5/1/2021

    Yule AM, Ijadi-Maghsoodi R, Bagot KS, Bath E. Support for Early-Career Female Physician-Scientists as Part of the COVID-19 Recovery Plan. Acad Med. 2021 May 01; 96(5):e16-e17. PMID: 33315597.

    Read at: PubMed
  • Published on 1/7/2021

    Bentley KH, Sakurai H, Lowman KL, Rines-Toth L, McKowen J, Pedrelli P, Evins AE, Yule AM. Validation of brief screening measures for depression and anxiety in young people with substance use disorders. J Affect Disord. 2021 03 01; 282:1021-1029. PMID: 33601674.

    Read at: PubMed

View 36 more publications: View full profile at BUMC

View all profiles